2021
DOI: 10.3390/diagnostics12010034
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the BioFire Gastrointestinal Panel to Detect Diarrheal Pathogens in Pediatric Patients

Abstract: Infectious diarrhea is a global pediatric health concern; therefore, rapid and accurate detection of enteropathogens is vital. We evaluated the BioFire® FilmArray® Gastrointestinal (GI) Panel with that of comparator laboratory tests. Stool samples of pediatric patients with diarrhea were prospectively collected and tested. As a comparator method for bacteria, culture, conventional PCR for diarrheagenic E. coli, and Allplex GI-Bacteria(I) Assay were tested. For discrepancy analysis, BD MAX Enteric Bacterial Pan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 25 publications
(28 reference statements)
0
4
0
Order By: Relevance
“…The BioFire FilmArray gastrointestinal panel (bioMérieux Canada Inc., Quebec, Canada) is a multiplexed nucleic acid (NA) amplification assay that simultaneously identifies 22 enteric pathogens, including targets for E. coli O157:H7 and the Shiga toxin ( stx 1 and stx 2 ) genes ( 8 ). It provides results with a 1-h run time and has excellent diagnostic sensitivity and specificity ( 9 ), and its usage has been demonstrated to reduce antibiotic use among hospitalized children with acute diarrhea ( 10 ). As such, it has the potential to rapidly identify STEC-infected children at risk for HUS while simultaneously ruling out such infections in the majority of children, thereby reducing the need for close monitoring while awaiting culture results ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…The BioFire FilmArray gastrointestinal panel (bioMérieux Canada Inc., Quebec, Canada) is a multiplexed nucleic acid (NA) amplification assay that simultaneously identifies 22 enteric pathogens, including targets for E. coli O157:H7 and the Shiga toxin ( stx 1 and stx 2 ) genes ( 8 ). It provides results with a 1-h run time and has excellent diagnostic sensitivity and specificity ( 9 ), and its usage has been demonstrated to reduce antibiotic use among hospitalized children with acute diarrhea ( 10 ). As such, it has the potential to rapidly identify STEC-infected children at risk for HUS while simultaneously ruling out such infections in the majority of children, thereby reducing the need for close monitoring while awaiting culture results ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…Multiplex PCR testing is very sensitive and detects presence of pathogen nucleic acid but not necessarily viable pathogen. The Biofire® GI PCR panel has shown high sensitivity and specificity in detection of diarrhoeal pathogens [ 63 ]. We intended to culture all human clinical Salmonella , Campylobacter and Shigella samples at NHL, however due to a lack of available resources this was not completed in most cases.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, multiplex PCR testing is very sensitive and detects presence of pathogen nucleic acid but not necessarily viable pathogen. The Biofire GI PCR panel has shown high sensitivity and specificity in detection of diarrhoeal pathogens (49). We intended to culture all human clinical Salmonella, Campylobacter and Shigella samples at NHL, however due to a lack of available resources this was not completed in most cases.…”
Section: Discussionmentioning
confidence: 99%